Literature DB >> 35368357

Confounding in Observational Studies Evaluating the Safety and Effectiveness of Medical Treatments.

Magdalene M Assimon1.   

Abstract

Entities:  

Keywords:  chronic kidney disease; confouding; observational research

Mesh：

Year:  2021        PMID： 35368357      PMCID： PMC8786092          DOI： 10.34067/KID.0007022020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  14 in total

Review 1.  The number, quality, and coverage of randomized controlled trials in nephrology.

Authors:  Giovanni F M Strippoli; Jonathan C Craig; Francesco P Schena
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

2.  Propensity score methods for confounding control in nonexperimental research.

Authors:  M Alan Brookhart; Richard Wyss; J Bradley Layton; Til Stürmer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

Review 3.  A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Authors:  Til Stürmer; Manisha Joshi; Robert J Glynn; Jerry Avorn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

4.  Confounding by indication.

Authors:  A M Walker
Journal:  Epidemiology       Date:  1996-07       Impact factor: 4.822

5.  Restriction of Pharmacoepidemiologic Cohorts to Initiators of Medications in Unrelated Preventive Drug Classes to Reduce Confounding by Frailty in Older Adults.

Authors:  Henry T Zhang; Leah J McGrath; Alan R Ellis; Richard Wyss; Jennifer L Lund; Til Stürmer
Journal:  Am J Epidemiol       Date:  2019-07-01       Impact factor: 4.897

6.  Confounding by Indication in Clinical Research.

Authors:  Demetrios N Kyriacou; Roger J Lewis
Journal:  JAMA       Date:  2016-11-01       Impact factor: 56.272

Review 7.  Merits and caveats of propensity scores to adjust for confounding.

Authors:  Edouard L Fu; Rolf H H Groenwold; Carmine Zoccali; Kitty J Jager; Merel van Diepen; Friedo W Dekker
Journal:  Nephrol Dial Transplant       Date:  2019-10-01       Impact factor: 5.992

Review 8.  Confounding and control of confounding in nonexperimental studies of medications in patients with CKD.

Authors:  Brian D Bradbury; David T Gilbertson; M Alan Brookhart; Ryan D Kilpatrick
Journal:  Adv Chronic Kidney Dis       Date:  2012-01       Impact factor: 3.620

9.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

10.  Paradoxical relations of drug treatment with mortality in older persons.

Authors:  R J Glynn; E L Knight; R Levin; J Avorn
Journal:  Epidemiology       Date:  2001-11       Impact factor: 4.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.